ISL
SMED

Ingalls & Snyder LLC’s Sharps Compliance Corp SMED Stock Holding History

Ingalls & Snyder LLC’s Portfolio SMED Stock Details SMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-16,700
Closed -$240K – 469
2021
Q1 		$240K Sell
16,700
-22,549
-57% -$290K 0.01% 394
2020
Q4 		$371K Hold
39,249
– – 0.02% 316
2020
Q3 		$246K Hold
39,249
– – 0.02% 323
2020
Q2 		$276K Sell
39,249
-233,720
-86% -$1.66M 0.02% 325
2020
Q1 		$2.17M Sell
272,969
-325
-0.1% -$1.67K 0.15% 116
2019
Q4 		$1.15M Sell
273,294
-10,675
-4% -$45.8K 0.06% 186
2019
Q3 		$1.18M Sell
283,969
-14
-0% -$53 0.06% 197
2019
Q2 		$1.01M Sell
283,983
-10,836
-4% -$37.5K 0.05% 223
2019
Q1 		$1.08M Sell
294,819
-10,871
-4% -$39.5K 0.05% 209
2018
Q4 		$1.05M Sell
305,690
-45,578
-13% -$157K 0.06% 200
2018
Q3 		$1.21M Buy
351,268
+292,018
+493% +$1.03M 0.05% 205
2018
Q2 		$219K Sell
59,250
-2,882
-5% -$11.4K 0.01% 368
2018
Q1 		$282K Sell
62,132
-6,410
-9% -$28.8K 0.01% 331
2017
Q4 		$280K Sell
68,542
-2,682
-4% -$11.3K 0.01% 329
2017
Q3 		$340K Sell
71,224
-5
-0% -$24 0.02% 280
2017
Q2 		$301K Sell
71,229
-150
-0.2% -$640 0.02% 294
2017
Q1 		$340K Sell
71,379
-250
-0.3% -$1.15K 0.02% 300
2016
Q4 		$274K Buy
71,629
+2,008
+3% +$8.15K 0.01% 330
2016
Q3 		$305K Sell
69,621
-2,716
-4% -$13.2K 0.02% 310
2016
Q2 		$318K Buy
72,337
+16,689
+30% +$79K 0.02% 311
2016
Q1 		$306K Buy
55,648
+18,752
+51% +$114K 0.02% 278
2015
Q4 		$320K Sell
36,896
-2,000
-5% -$17.3K 0.02% 283
2015
Q3 		$340K Sell
38,896
-9,461
-20% -$68.4K 0.02% 261
2015
Q2 		$336K Buy
48,357
+1,200
+3% +$7.51K 0.02% 276
2015
Q1 		$299K Buy
47,157
+6,991
+17% +$35.3K 0.02% 290
2014
Q4 		$171K Buy
40,166
+7,320
+22% +$32.5K 0.01% 345
2014
Q3 		$143K Buy
32,846
+10,121
+45% +$45.6K 0.01% 362
2014
Q2 		$99K Buy
+22,725
New +$93.9K ﹤0.01% 371

Other funds holding SMED

RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ingalls & Snyder LLC's SMED Position: Q2 2021 in Review

Ingalls & Snyder LLC sold out of Sharps Compliance Corp (SMED) in Q2 2021, closing a stake of 16,700 shares — an estimated $240K sold.

Ingalls & Snyder LLC first reported a position in SMED in Q2 2014 and held it in 28 quarters. The position peaked at $2.17M in Q1 2020. 83 funds tracked by Wall St. Rank hold SMED as of Q2 2021.

  • Ingalls & Snyder LLC reported no remaining Sharps Compliance Corp position as of Q2 2021 after selling out during the quarter.
  • Ingalls & Snyder LLC sold 16,700 Sharps Compliance Corp shares in Q2 2021, an estimated $240K.
  • Ingalls & Snyder LLC first reported a position in Sharps Compliance Corp in Q2 2014 and held it in 28 quarters.
  • Ingalls & Snyder LLC's Sharps Compliance Corp position peaked at $2.17M in Q1 2020.
  • 83 funds tracked by Wall St. Rank held Sharps Compliance Corp as of Q2 2021.

Based on Ingalls & Snyder LLC's 13F filing for Q2 2021, filed 3 Aug 2021.